all AI news
Isomorphic signs drug discovery deals with Eli Lilly and Novartis
Jan. 8, 2024, 9:04 a.m. | Leigh Mc Gowran
Silicon RepublicSilicon Republic www.siliconrepublic.com
The company aims to use the power of AI to tackle various diseases and could receive nearly $3bn from its new research collaborations.
Read more: Isomorphic signs drug discovery deals with Eli Lilly and Novartis
ai alphabet collaborations deals deals done discovery diseases drug discovery eli lilly funding and investment innovation novartis power research the company
More from www.siliconrepublic.com / Silicon RepublicSilicon Republic
Apple unveils new iPad Pro and its AI-focused M4 chip
1 day, 11 hours ago |
www.siliconrepublic.com
Akamai to acquire Noname Security in $450m deal
2 days, 4 hours ago |
www.siliconrepublic.com
Amazon to invest $9bn for cloud infrastructure in Singapore
2 days, 11 hours ago |
www.siliconrepublic.com
Jobs in AI, ML, Big Data
Artificial Intelligence – Bioinformatic Expert
@ University of Texas Medical Branch | Galveston, TX
Lead Developer (AI)
@ Cere Network | San Francisco, US
Research Engineer
@ Allora Labs | Remote
Ecosystem Manager
@ Allora Labs | Remote
Founding AI Engineer, Agents
@ Occam AI | New York
AI Engineer Intern, Agents
@ Occam AI | US